Status:
COMPLETED
Anastrozole Administration in Elderly Hypogonadal Men
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Hypogonadism
Eligibility:
MALE
60+ years
Phase:
PHASE2
Brief Summary
The purpose of the study is to assess the effects of sustained aromatase inhibitor therapy to reduce estrogen levels in elderly men with mild hypogonadism (a decreased level of sex hormones).
Detailed Description
It has long been accepted that aging in men is associated with a slow, steady decline in gonadal androgen (male sex hormone) production. Several studies have explored androgen replacement, but the saf...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Men ages 60 and older
- Serum testosterone between 150-300 ng/dL
- Symptoms suggestive of androgen deficiency
Exclusion
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT00136695
Start Date
October 1 2004
End Date
October 1 2009
Last Update
September 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Clinical Research Center, Massachusetts General Hospital
Boston, Massachusetts, United States, 02114